Moreover, high tumor PD-L2 was clinically associated with improved 5-year OS in stage III (p = 0.0492, Fig. 2C) and stage IV (p = 0.0561, Fig. 2E) colon carcinoma patients who received postoperative chemotherapy. This evidence concerns the gene PDCD1LG2 and colon carcinoma.